To study the maternal contribution to early human embryogenesis by describing the transcriptional dynamics and regulatory roles of maternal effect genes (MEGs) and transcription factors (TFs)
To evaluate the association between per- and polyfluoroalkyl substances (PFAS) in follicular fluid (FF) and live birth after in vitro fertilization (IVF) and characterize the FF metabolome in
To study whether an artificial intelligence (AI)-derived oocyte morphology score (MAGENTA) predicts fertilization, embryo development, and euploidy, and whether integrating MAGENTA with clinical
To study the diagnostic concordance and tolerability of hysterosalpingo-foam sonography (HyFoSy) compared with hysterosalpingography (HSG) in the evaluation of tubal patency.
To characterize the dynamic secretion patterns of extracellular cytokines in 3 in vitro human endometrial culture models subjected to a hormonally simulated 28-day menstrual cycle and to assess
To investigate the metabolic alterations at the maternal-fetal interface in missed miscarriage (MM) using untargeted metabolomic and lipidomic profiling of paired villous and decidual tissues.
To investigate the therapeutic potential of ANA-12 in restoring testicular health by modulating local neurochemical balance in adult rats of passive smoking, secondhand smoking or environmental
To characterize the redistribution patterns of zinc and calcium ions during human sperm capacitation and to investigate their roles in sperm maturation and fertilization.
To study ameliorative effects of silymarin on hormonal balance, oxidative stress markers, sperm quality and testicular histopathology in male mice exposed to cyclophosphamide (CP).
Fertility treatments have been associated with increased risks of adverse birth outcomes, including congenital anomalies. However, confounding by indication related to underlying infertility
Displaying 81 to 90 of 1735 records
